-Christian Brander Researcher Activity Profile

Research Author Detailed Information 

Christian Brander Publication Rate By Year

Christian Brander has published 1 paper(s) in 2005, 23 paper(s) in 2007, 8 paper(s) in 2008, for a total of 32 research publications in total.

Christian C Brander Author Information

LAST NAME: brander

FIRST NAME: Christian

INITIALS: c

AFFILIATION:

Papers

Christian Brander's Publication Record

1. Extensive intrasubtype recombination in South African human immunodeficiency virus type 1 subtype C infections. Year Published: 2007
Department of Microbiology, University of Washington, 1959 NE Pacific Street, Box 358070, Seattle, WA 98195-8070, USA. cmr@u.washington.edu
2. Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes. Year Published: 2007
Partners AIDS Research Center, Massachusetts General Hospital East, 149 13th Street, Charlestown, MA 02129-2000, USA.
3. Characterization of full-length hepatitis C virus genotype 4 sequences. Year Published: 2007
Partners AIDS Research Center, Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA.
4. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. Year Published: 2007
Partners AIDS Research Center, Massachusetts General Hospital, 149 13th Street, Room 5212, Charlestown, MA 02129, USA.
5. HIV Viral Diversity and Escape from Cellular Immunity. Year Published: 2007
Partners AIDS Research Center, 5th Floor MGH East, #5239, 149 13th Street, Charlestown, MA 02129-2000, USA. cbrander@partners.org.
6. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Year Published: 2007
Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
7. Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. Year Published: 2007
Partners AIDS Research Center, Infectious Disease Unit, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, MA 02129, USA.
8. Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope. Year Published: 2007
Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.
9. A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. Year Published: 2007
Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
10. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. Year Published: 2007
Department of Pediatrics, University of Oxford, Peter Medawar Building for Pathogen Research, South Parks Rd., Oxford OX1 3SY, United Kingdom.
11. HIV-1 over time: fitness loss or robustness gain? Year Published: 2007
12. Extensive HLA class I allele promiscuity among viral CTL epitopes. Year Published: 2007
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
13. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. Year Published: 2007
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
14. A statistical framework for modeling HLA-dependent T cell response data. Year Published: 2007
Microsoft Research, Redmond, Washington, USA.
15. Increased sequence diversity coverage improves detection of HIV-specific T cell responses. Year Published: 2007
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.
16. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. Year Published: 2007
Partners AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, MA 02129, USA.
17. A statistical framework for modeling HLA-dependent T cell response data. Year Published: 2007
Microsoft Research, Redmond, Washington, USA.
18. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. Year Published: 2007
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
19. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. Year Published: 2007
Partners AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, MA 02129, USA.
20. Increased sequence diversity coverage improves detection of HIV-specific T cell responses. Year Published: 2007
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.
21. A statistical framework for modeling HLA-dependent T cell response data. Year Published: 2007
Microsoft Research, Redmond, Washington, USA.
22. Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral Loads. Year Published: 2008
Department of Microbiology, University of Washington School of Medicine, Seattle, Washington, United States of America.
23. HIV-1 over time: fitness loss or robustness gain? Year Published: 2007
24. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. Year Published: 2007
Department of Pediatrics, University of Oxford, Peter Medawar Building for Pathogen Research, South Parks Rd., Oxford OX1 3SY, United Kingdom.
25. [HIV-1 vaccination--is there hope?] Year Published: 2005
Abteilung für Infektionskrankheiten und Spitalhygiene, Universitätsspital Zürich, Zürich. roberto.speck@usz.ch
26. HLA class I supertypes: a revised and updated classification. Year Published: 2008
Division of Vaccine Discovery, The La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. alex@liai.org.
27. HLA class I supertypes: a revised and updated classification. Year Published: 2008
Division of Vaccine Discovery, The La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. jsidney@liai.org
28. Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance. Year Published: 2008
Massachusetts General Hospital and Harvard Medical School, Partners AIDS Research Center, MGH East no. 5239, 149 13th St., Charlestown, MA 02143, USA.
29. Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity. Year Published: 2008
Albert Einstein College of Medicine, Forchheimer Building, Room 408, 1300 Morris Park Ave., Bronx, NY 10461, USA.
30. Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1. Year Published: 2008
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
31. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection. Year Published: 2008
Division of Gastroenterology and Hepatology, University Hospital of Geneva, Geneva, Switzerland.
32. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection. Year Published: 2008
Division of Gastroenterology and Hepatology, University Hospital of Geneva, Geneva, Switzerland.